Trade HUMA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Humacyte, Inc. (HUMA) is trading at US$0.65, down 6.16% today as of Aug 28, 12:21 EDT. The company has a market capitalisation of US$178.4M. Over the past 52 weeks, HUMA has traded between US$0.53 and US$2.55. On Syfe you can trade HUMA with $0 commission and add it to your watchlist.
| Previous close | US$0.69 |
|---|---|
| Market cap | US$178.4M |
| 52-week range | US$0.53 – US$2.55 |
| Volume | 2.9M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Humacyte, Inc.
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Year: 2021
Humacyte Says US FDA Accepted IND for Human Trial of Coronary Tissue Engineered Vessel in Surgery
Jul 27, 12:54 PM · MT Newswires
Humacyte Says ATEV Met Late-Stage Study Endpoint in Interim Analysis, Launches Public Offering; Shares Fall
Jun 10, 8:51 PM · MT Newswires
Humacyte Realigns Ex-US Rights to Symvess With Fresenius Medical Care
Apr 24, 12:53 PM · MT Newswires
Humacyte Says Israeli Health Ministry Accepts Marketing Authorization Application for Symvess
Apr 21, 1:48 PM · MT Newswires
Humacyte, Inc. (HUMA) stock is trading at US$0.65, -6.16% from the previous close of US$0.69.
The market cap for Humacyte, Inc. (HUMA) stock is approximately US$178.4M.
The 52-week high for Humacyte, Inc. (HUMA) stock is US$2.55.
The 52-week low for Humacyte, Inc. (HUMA) stock is US$0.53.
Humacyte, Inc. (HUMA) does not currently pay a dividend.
Stay on top of HUMA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
